New AI eye screening tool could save millions from vision loss
NCT ID NCT06343350
First seen Mar 14, 2026 · Last updated Apr 29, 2026 · Updated 5 times
Summary
This study tested a new automated screening tool called OPTDR01 to detect diabetic retinopathy, a leading cause of vision loss, in people with diabetes. The tool is designed for use in primary care settings to make screening more accessible, especially for underserved groups. Researchers enrolled 300 adults to see how well the tool works and how easy it is to use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Gastro SB
Chula Vista, California, 91910, United States
-
Gulf Coast Clinical Research
Houston, Texas, 77070, United States
-
Triwest Research Associates
San Diego, California, 92108, United States
Conditions
Explore the condition pages connected to this study.